Literature DB >> 22987804

Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period.

Tiffany T-Y Lee1, Matthew N Hill, Cecilia J Hillard, Boris B Gorzalka.   

Abstract

Fatty acid amide hydrolase (FAAH) regulates tissue concentrations of N-acylethanolamines (NAEs), including the endocannabinoid, N-arachidonylethanolamide (anandamide, AEA). FAAH activity and NAEs are widely distributed throughout the brain and FAAH activity regulates an array of processes including emotion, cognition, inflammation, and feeding. However, there is relatively little research describing how this system develops throughout adolescence, particularly within limbic circuits regulating stress and reward processing. Thus, this study characterized temporal changes in NAE content (AEA, oleoylethanolamine [OEA], and palmitoylethanolamide [PEA]) and FAAH activity across the peri-adolescent period, in four corticolimbic structures (amygdala, hippocampus, prefrontal cortex, and hypothalamus). Brain tissue of male Sprague-Dawley rats was collected on postnatal days (PND) 25, 35, 45, and 70, representing pre-adolescence, early- to mid-adolescence, late adolescence, and adulthood, respectively. Tissue was analyzed for AEA, OEA, and PEA content as well as FAAH activity at each time point. AEA, OEA, and PEA exhibited a similar temporal pattern in all four brain regions. NAE concentrations were lowest at PND 25 and highest at PND 35. NAE concentrations decreased between PNDs 35 and 45 and increased between PNDs 45 and 70. FAAH activity mirrored the pattern of NAE content in which it decreased between PNDs 25 and 35, increased between PNDs 35 and 45, and decreased between PNDs 45 and 70. These age-dependent patterns of NAE content and FAAH activity demonstrate temporal specificity to the development of this system and could contribute to alterations in stress sensitivity, emotionality, and executive function which also fluctuate during this developmental period.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987804      PMCID: PMC3510355          DOI: 10.1002/syn.21609

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  51 in total

Review 1.  Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain.

Authors:  Harald S Hansen
Journal:  Exp Neurol       Date:  2010-03-29       Impact factor: 5.330

2.  Selective early-acquired fear memories undergo temporary suppression during adolescence.

Authors:  Siobhan S Pattwell; Kevin G Bath; B J Casey; Ipe Ninan; Francis S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 3.  Cellular signal transduction by anandamide and 2-arachidonoylglycerol.

Authors:  A C Howlett; S Mukhopadhyay
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

Review 4.  Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis.

Authors:  M N Hill; J G Tasker
Journal:  Neuroscience       Date:  2011-12-24       Impact factor: 3.590

5.  Dynamic mapping of normal human hippocampal development.

Authors:  Nitin Gogtay; Tom F Nugent; David H Herman; Anna Ordonez; Deanna Greenstein; Kiralee M Hayashi; Liv Clasen; Arthur W Toga; Jay N Giedd; Judith L Rapoport; Paul M Thompson
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

6.  Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

Authors:  Kyle P Chiang; Alexandra L Gerber; Jack C Sipe; Benjamin F Cravatt
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

Review 7.  An introduction to the endocannabinoid system: from the early to the latest concepts.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-02       Impact factor: 4.690

8.  Estrogen recruits the endocannabinoid system to modulate emotionality.

Authors:  Matthew N Hill; Eda S Karacabeyli; Boris B Gorzalka
Journal:  Psychoneuroendocrinology       Date:  2007-03-27       Impact factor: 4.905

Review 9.  Endocannabinoid functions controlling neuronal specification during brain development.

Authors:  Tibor Harkany; Erik Keimpema; Klaudia Barabás; Jan Mulder
Journal:  Mol Cell Endocrinol       Date:  2008-03-04       Impact factor: 4.102

10.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

View more
  21 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

Review 2.  Neural substrates underlying the negative impact of cannabinoid exposure during adolescence.

Authors:  Hanna M Molla; Kuei Y Tseng
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

Review 3.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

4.  Δ9-Tetrahydrocannabinol changes the brain lipidome and transcriptome differentially in the adolescent and the adult.

Authors:  Emma Leishman; Michelle Murphy; Ken Mackie; Heather B Bradshaw
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-02-08       Impact factor: 4.698

Review 5.  The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development.

Authors:  Heidi C Meyer; Francis S Lee; Dylan G Gee
Journal:  Neuropsychopharmacology       Date:  2017-07-07       Impact factor: 7.853

6.  Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.

Authors:  Monika Feliszek; Laura Bindila; Beat Lutz; Andreas Zimmer; Andras Bilkei-Gorzo; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-17       Impact factor: 3.000

7.  Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling.

Authors:  Laura Markey; Andrew Hooper; Laverne C Melon; Samantha Baglot; Matthew N Hill; Jamie Maguire; Carol A Kumamoto
Journal:  Psychoneuroendocrinology       Date:  2020-07-24       Impact factor: 4.905

8.  Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.

Authors:  Sylvina M Raver; Asaf Keller
Journal:  Neuropharmacology       Date:  2014-07-15       Impact factor: 5.250

Review 9.  Developmental regulation of fear learning and anxiety behavior by endocannabinoids.

Authors:  T T-Y Lee; M N Hill; F S Lee
Journal:  Genes Brain Behav       Date:  2015-11-05       Impact factor: 3.449

10.  Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species.

Authors:  Dylan G Gee; Robert N Fetcho; Deqiang Jing; Anfei Li; Charles E Glatt; Andrew T Drysdale; Alexandra O Cohen; Danielle V Dellarco; Rui R Yang; Anders M Dale; Terry L Jernigan; Francis S Lee; B J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.